Market Introduction
The North America joint pain injection market is a highly fragmented market with the presence of considerable regional and local players providing numerous solutions for companies investing in the market arena. Hyaluronic acid injections offered by companies are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function. Corticosteroids are also used to treat sports-related injuries. Sports injuries are caused due to direct impact, or the application of force that is larger than the body part can withstand. The most common sport injuries are sprains, strains, joint injuries, and bruises. As per the National Safety Council (NSC), in 2019, exercise accounted for ~468,000 injuries in the US, the most of any category of sports and recreation. People involved in football, bicycling, basketball, playground, and soccer activities contributed to the highest number of emergency department (ED) visits in that year. It also states sport injuries affect over thousands of youth population engaged in various sports.
In North America, especially the US witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market. In order to manage the outbreak, government took preventive measures including total lockdowns and social distancing policies. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Cancelling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units is also negatively affecting the growth of the joint pain injection market. However, at end of second quarter, restrictions on orthopedic procedures were lifted by the US government and patients were also allowed to visit orthopedic offices. Such decisions helped market players to recover their losses during the pandemic.
Market Overview and Dynamics
The joint pain injection market in North America is expected to grow from US$ 2,785.42 million in 2021 to US$ 5,010.47 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. Countries in North America are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Flourishing domestic pharmaceutical market and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies. According to a report published by the US Department of Health & Human Services in the year 2018 stated that near 700,000 knee replacement surgeries in US are being carried out every year. It is also expected that the number is likely to reach approximately 3.48 million surgeries per year till 2030. Other than the knee surgeries, the incidences of the hip replacement surgeries are also increasing in the ageing population. As per the Agency for Healthcare Research and Quality, over 450,000 total hip replacements are performed every year in the United States. Furthermore, as per the report published in The Journal of Rheumatology in the year 2018, stated that in US incidence of total hip replacement surgeries are expected to increase by 129% in 2030 which is around 850,000 replacements procedures and by 284% in 2040 that is about 1,429,000 replacements. The advancement is the technology has led into the reduction of the time for the surgeries.
Key Market Segments
Based on drugs, the corticosteroid segment accounted for the largest share of the North America joint pain injection market in 2020. Based on joint type, the knee segment accounted for the largest share of the North America joint pain injection market in 2020. Based on distribution channel, the hospitals pharmacies segment accounted for the largest share of the North America joint pain injection market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America joint pain injection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report include Chugai Pharmaceutical Co., Ltd.; Bioventus Inc.; Fidia Pharma USA Inc.; Flexion Therapeutics, Inc.; Seikagaku Corporation; Ferring B.V.; Sanofi; Anika Therapeutics, Inc; OrthogenRx, Inc. and Teva Pharmaceutical Industries Ltd.
Reasons to buy report
North America Joint Pain Injection Market Segmentation
North America Joint Pain Injection Market -By Drugs
North America Joint Pain Injection Market -By Joint Type
North America Joint Pain Injection Market -By Distribution Channel
North America Joint Pain Injection Market – By Country
North America Joint Pain Injection Market – Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,785.42 Million |
| Market Size by 2028 | US$ 5,010.47 Million |
| CAGR (2021 - 2028) | 8.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Drugs
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Joint Pain Injection Market is valued at US$ 2,785.42 Million in 2021, it is projected to reach US$ 5,010.47 Million by 2028.
As per our report North America Joint Pain Injection Market, the market size is valued at US$ 2,785.42 Million in 2021, projecting it to reach US$ 5,010.47 Million by 2028. This translates to a CAGR of approximately 8.7% during the forecast period.
The North America Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Joint Pain Injection Market report:
The North America Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Joint Pain Injection Market
